Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Enterococcus Faecium and Bacillus Subtilis-Containing Multispecies Probiotic Supplementation on the Therapeutic Efficacy of Rifaximin α in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Prospective, Randomized, Placebo-controlled Trial

NCT07426705 is registered in ClinicalTrials.gov with Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji as lead sponsor.

NCT NCT07426705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07426705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Enterococcus Faecium and Bacillus Subtilis-Containing Multispecies Probiotic Supplementation on the Therapeutic Efficacy of Rifaximin α in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Prospective, Randomized, Placebo-controlled Trial
Lead sponsor
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 15, 2026
Completion date
July 15, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ibs, small intestinal bacterial overgrowth syndrome (sibo)